1-5 of 5
Pratik Multani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2074: ORIC-533, a small molecule CD73 inhibitor with best-in-class properties, reversesimmunosuppression and has potential as an immunomodulatory therapy in patients with multiple myeloma

Free
Melissa R. Junttila, Arghya Ray, Robert Warne, Xi Chen, Ting Du, Dena Sutimantanapi, Jae H. Chang, Brian Blank, Jared Moore, Chudi O. Ndubaku, Tatiana Zavorotinskaya, Pratik Multani, Omar Nadeem, Dharminder Chauhan, Kenneth C. Anderson, Lori S. Friedman
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 2074.
https://doi.org/10.1158/1538-7445.AM2022-2074
Published: 15 June 2022
View articletitled, Abstract 2074: ORIC-533, a small molecule CD73 inhibitor with best-in-class properties, reversesimmunosuppression and has potential as an immunomodulatory therapy in patients with multiple myeloma
Journal Articles

Abstract 2136: Entrectinib is effective against the gatekeeper and other emerging resistance mutations in NTRK-, ROS1- and ALK- rearranged cancers

Free
Ge Wei, Elena Ardini, Roopal Patel, Nicholas Cam, Jason Harris, Jean-Michel Vernier, Nanqun Zhu, Litain Yeh, Robert Shoemaker, Pratik Multani, Zachary Hornby, Robert Wild, Gary G. Li
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 2136.
https://doi.org/10.1158/1538-7445.AM2016-2136
Published: 15 July 2016
View articletitled, Abstract 2136: Entrectinib is effective against the gatekeeper and other emerging resistance mutations in NTRK-, ROS1- and ALK- rearranged cancers
Journal Articles

Abstract 4780: RXDX-107 exhibits multiple mechanisms of intracellular delivery and results in extensive drug-induced interstrand crosslinks in solid tumor preclinical models

Free
Leenus Martin, Roopal Patel, Michael Johnson, Jerry Cao, Peter Chua, Colin Walsh, Jennifer Oliver, Pratik Multani, Robert Wild, Ralph Lin, Gary G. Li
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4780.
https://doi.org/10.1158/1538-7445.AM2016-4780
Published: 15 July 2016
View articletitled, Abstract 4780: RXDX-107 exhibits multiple mechanisms of intracellular delivery and results in extensive drug-induced interstrand crosslinks in solid tumor preclinical models
Journal Articles

Development, validation, and application of methods for the assessment of P-glycoprotein (P-gp) function and inhibition in a clinical trial of zosuquidar infusion in patients with acute myeloid leukemia (AML)

Free
John Marcelletti, Pratik Multani, Jeffrey Lancet, Maria Baer, Larry Cripe, Branimir Sikic
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 933.
Published: 01 May 2007
View articletitled, Development, validation, and application of methods for the assessment of P-glycoprotein (P-gp) function and inhibition in a clinical trial of zosuquidar infusion in patients with acute myeloid leukemia (AML)
Journal Articles

Translational Research: Walking the Bridge between Idea and Cure—Seventeenth Bruce F. Cain Memorial Award Lecture

Free
Bruce A. Chabner, Anthony L. Boral, Pratik Multani
Journal: Cancer Research
Cancer Res (1998) 58 (19): 4211–4216.
Published: 01 October 1998
View articletitled, Translational Research: Walking the Bridge between Idea and Cure—Seventeenth Bruce F. Cain Memorial Award Lecture
Open the PDF for Translational Research: Walking the Bridge between Idea and Cure—Seventeenth Bruce F. Cain Memorial Award Lecture in another window